相似文献
1
Primary prevention with the ICD in clinical practice: not as straightforward as the guidelines suggest?
Neth Heart J. 2009 Mar;17(3):107-10. doi: 10.1007/BF03086228.
2
Outcomes in African Americans undergoing cardioverter-defibrillator implantation for primary prevention of sudden cardiac death: findings from the Prospective Observational Study of Implantable Cardioverter-Defibrillators (PROSE-ICD).
Heart Rhythm. 2014 Aug;11(8):1377-83. doi: 10.1016/j.hrthm.2014.04.039. Epub 2014 May 2.
3
Systematic Review for the 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.
J Am Coll Cardiol. 2018 Oct 2;72(14):1653-1676. doi: 10.1016/j.jacc.2017.10.052. Epub 2017 Oct 30.
4
Improving the Use of Primary Prevention Implantable Cardioverter-Defibrillators Therapy With Validated Patient-Centric Risk Estimates.
JACC Clin Electrophysiol. 2018 Aug;4(8):1089-1102. doi: 10.1016/j.jacep.2018.04.015. Epub 2018 Jun 27.
5
Kidney dysfunction and deterioration of ejection fraction pose independent risk factors for mortality in implantable cardioverter-defibrillator recipients for primary prevention.
Clin Cardiol. 2012 Sep;35(9):575-9. doi: 10.1002/clc.22018. Epub 2012 Jun 15.
6
Frequency and determinants of implantable cardioverter defibrillator deployment among primary prevention candidates with subsequent sudden cardiac arrest in the community.
Circulation. 2013 Oct 15;128(16):1733-8. doi: 10.1161/CIRCULATIONAHA.113.002539. Epub 2013 Sep 18.
7
Impact of a hybrid decision support system to improve the adherence to implantable cardioverter defibrillator therapy guidelines for primary prevention of sudden cardiac death.
Int J Med Inform. 2018 Jun;114:76-80. doi: 10.1016/j.ijmedinf.2018.03.016. Epub 2018 Mar 27.
8
[14-year experience with implantable cardioverter/defibrillators: determination of prognosis and discharge behavior].
Z Kardiol. 2000;89 Suppl 3:194-205.
9
Right Ventricular Dysfunction and the Effect of Defibrillator Implantation in Patients With Nonischemic Systolic Heart Failure.
Circ Arrhythm Electrophysiol. 2019 Mar;12(3):e007022. doi: 10.1161/CIRCEP.118.007022.
10
Clinical Impact of Implantable Cardioverter-Defibrillator Therapy and Mortality Prediction Model for Effective Primary Prevention in Korean Patients.
J Korean Med Sci. 2020 Mar 9;35(9):e49. doi: 10.3346/jkms.2020.35.e49.
引用本文的文献
1
Dutch outcome in implantable cardioverter-defibrillator therapy (DO-IT): registry design and baseline characteristics of a prospective observational cohort study to predict appropriate indication for implantable cardioverter-defibrillator.
Neth Heart J. 2017 Oct;25(10):574-580. doi: 10.1007/s12471-017-1016-x.
2
Implementation of guidelines for implantable cardioverter-defibrillator therapy in clinical practice: Which patients do benefit?
Neth Heart J. 2013 Jun;21(6):274-83. doi: 10.1007/s12471-013-0407-x.
3
Fresh arrhythmia news: suitable for daily use?
Neth Heart J. 2011 Jan;19(1):3-5. doi: 10.1007/s12471-010-0054-4.
4
Improvements in 25 Years of Implantable Cardioverter Defibrillator Therapy.
Neth Heart J. 2011 Jan;19(1):24-30. doi: 10.1007/s12471-010-0047-3. Epub 2010 Dec 22.
5
Primary prevention with ICDs, are we on the right track?
Neth Heart J. 2009 Mar;17(3):92-4. doi: 10.1007/BF03086225.
本文引用的文献
1
A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death.
J Am Coll Cardiol. 2008 Sep 30;52(14):1111-21. doi: 10.1016/j.jacc.2008.05.058.
2
The year in arrhythmias--2007: Part I.
Heart Rhythm. 2008 May;5(5):742-8. doi: 10.1016/j.hrthm.2008.03.012. Epub 2008 Mar 14.
3
Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact.
J Am Coll Cardiol. 2008 Apr 8;51(14):1357-65. doi: 10.1016/j.jacc.2007.09.073.
4
Performance of conventional echocardiographic parameters and myocardial measurements in the sequential evaluation of left ventricular function.
Am J Cardiol. 2008 Mar 1;101(5):706-11. doi: 10.1016/j.amjcard.2007.10.037. Epub 2007 Dec 21.
5
Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction.
J Am Coll Cardiol. 2008 Jan 22;51(3):288-96. doi: 10.1016/j.jacc.2007.08.058.
6
Is microvolt T-wave alternans the answer to risk stratification in heart failure?
Circulation. 2007 Dec 18;116(25):2984-91. doi: 10.1161/CIRCULATIONAHA.107.699918.
7
Complications associated with generator replacement in response to device advisories.
J Cardiovasc Electrophysiol. 2008 Mar;19(3):266-9. doi: 10.1111/j.1540-8167.2007.01047.x. Epub 2007 Dec 12.
8
Outcomes of elderly heart failure recipients of ICD and CRT.
Int J Cardiol. 2008 Apr 10;125(2):154-60. doi: 10.1016/j.ijcard.2007.10.007. Epub 2007 Oct 31.
9
Limitations of ejection fraction for prediction of sudden death risk in patients with coronary artery disease: lessons from the MUSTT study.
J Am Coll Cardiol. 2007 Sep 18;50(12):1150-7. doi: 10.1016/j.jacc.2007.04.095. Epub 2007 Sep 4.
10
Mortality in patients with left ventricular ejection fraction </=30% after primary percutaneous coronary intervention for ST-elevation myocardial infarction.
Am J Cardiol. 2007 Sep 1;100(5):793-7. doi: 10.1016/j.amjcard.2007.03.101. Epub 2007 Jun 14.
Zotero 插件